Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease.

IF 1.1 Q4 PATHOLOGY Turkish Journal of Pathology Pub Date : 2022-01-01 DOI:10.5146/tjpath.2021.01564
Ceren Hangul, Oznur Tokta, Sibel Berker Karauzum, Bahar Akkaya, Hulya Yildirim, Funda Tayfun Kupesiz, Ayse Nur Akinel
{"title":"Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease.","authors":"Ceren Hangul,&nbsp;Oznur Tokta,&nbsp;Sibel Berker Karauzum,&nbsp;Bahar Akkaya,&nbsp;Hulya Yildirim,&nbsp;Funda Tayfun Kupesiz,&nbsp;Ayse Nur Akinel","doi":"10.5146/tjpath.2021.01564","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>DUX4 is an embryonic transcription factor (TF) later silenced in somatic tissues, while active in germline testis cells. Re-expression in somatic cells has been revealed to be present in pathologic conditions such as dystrophy, leukemia, and other cancer types. Embryonic cells, cancer cells and testis cells that show DUX4 expression are pluri-multipotent cells. This lead us to question \"Could DUX4 be a TF that is active in certain types of potent somatic cells?\" As a perfect reflection of the potent cell pool, we aimed to reveal DUX4 expression in the bone marrow.</p><p><strong>Material and method: </strong>Bone marrow aspiration materials of seven healthy donors aged between 3 and 32 (2 males/5 females) were investigated with qPCR analysis after RNA isolation for the presence of DUX4 full length mRNA expression. Samples have been investigated for protein existence of DUX4 via immunohistochemistry in two donors that had sufficient aspiration material.</p><p><strong>Results: </strong>DUX4 mRNA expression was present in all donors, with higher expression compared to B-actin. DUX4 positive stained cells were also detected by immunohistochemistry.</p><p><strong>Conclusion: </strong>With these results, novel expression for DUX4 in hematopoietic tissue is described. Further studies on the function of DUX4 in hematopoietic cells can shed light on DUX4-related pathways, and contribute to the treatment of DUX4-related diseases such as B-ALL, other cancers, and facioscapulohumeral muscular dystrophy.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508413/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5146/tjpath.2021.01564","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: DUX4 is an embryonic transcription factor (TF) later silenced in somatic tissues, while active in germline testis cells. Re-expression in somatic cells has been revealed to be present in pathologic conditions such as dystrophy, leukemia, and other cancer types. Embryonic cells, cancer cells and testis cells that show DUX4 expression are pluri-multipotent cells. This lead us to question "Could DUX4 be a TF that is active in certain types of potent somatic cells?" As a perfect reflection of the potent cell pool, we aimed to reveal DUX4 expression in the bone marrow.

Material and method: Bone marrow aspiration materials of seven healthy donors aged between 3 and 32 (2 males/5 females) were investigated with qPCR analysis after RNA isolation for the presence of DUX4 full length mRNA expression. Samples have been investigated for protein existence of DUX4 via immunohistochemistry in two donors that had sufficient aspiration material.

Results: DUX4 mRNA expression was present in all donors, with higher expression compared to B-actin. DUX4 positive stained cells were also detected by immunohistochemistry.

Conclusion: With these results, novel expression for DUX4 in hematopoietic tissue is described. Further studies on the function of DUX4 in hematopoietic cells can shed light on DUX4-related pathways, and contribute to the treatment of DUX4-related diseases such as B-ALL, other cancers, and facioscapulohumeral muscular dystrophy.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
DUX4在骨髓中的表达分析及对DUX4健康和疾病功能的再探讨。
目的:DUX4是一种胚胎转录因子(TF),后来在体细胞组织中沉默,但在生殖系睾丸细胞中具有活性。体细胞中的再表达已被发现存在于病理条件下,如营养不良、白血病和其他癌症类型。显示DUX4表达的胚胎细胞、癌症细胞和睾丸细胞是多能干细胞。这让我们产生了一个问题:“DUX4可能是一种在某些类型的强效体细胞中具有活性的TF吗?”作为强效细胞库的完美反映,我们旨在揭示DUX4在骨髓中的表达。材料和方法:在RNA分离后,用qPCR分析对7名年龄在3至32岁之间的健康捐献者(2名男性/5名女性)的骨髓抽吸材料进行DUX4全长mRNA表达的研究。已经通过免疫组织化学在具有足够抽吸材料的两个供体中研究了样品中DUX4的蛋白质存在。结果:DUX4 mRNA在所有供体中均有表达,与B-肌动蛋白相比表达更高。免疫组化法检测DUX4阳性染色细胞。结论:利用这些结果,描述了DUX4在造血组织中的新表达。对DUX4在造血细胞中的功能的进一步研究可以阐明DUX4相关途径,并有助于治疗DUX4相关性疾病,如B-ALL、其他癌症和面肩肱肌营养不良。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.90
自引率
10.00%
发文量
23
审稿时长
14 weeks
期刊最新文献
Dermatofibroma with Verocay Body-Type Palisading Features and a Brief Discussion on Potential Schwannoma Mimickers of the Skin. 25-Year Storage of Human Choroid Plexus in Methyl Salicylate Preserves Its Antigen Immunoreactivity. Histoplasmosis of the Head and Neck Region Mimicking Malignancy: A Clinic-Pathological Predicament. Neuroendocrine Tumor of the Fallopian Tube and Serous Adenocarcinoma of the Ovary: Multicentric Primary Tumors. Impact of COVID-19 Pandemic on Pathology Residency Program: An Experience from India.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1